Skip to main content

Table 2 Demographic and diagnostic characteristics among men with PCa from clinical registries in SA and Victoria

From: A retrospective analysis of Victorian and South Australian clinical registries for prostate cancer: trends in clinical presentation and management of the disease

 

Patients, N

%

Included into the study

13,598

100

State

 SA

3,526

25.9

 Victoria

10,072

74.1

Age groups

  

  < 55

2,059

15.1

 56–65

4,851

35.7

 65–75

4,711

34.6

  > 75

1,977

14.5

 Age (mean, SD)

65.4 (9.6)

 

Residential area

 Metropolitan

9,586

70.5

 Regional/Rural

3,250

23.9

 Unknown

762

5.6

SEIFA

 Lowest 10 % (0–20 %)

1,751

12.9

 Lowest 21–40 %

2,245

16.5

 Lowest 41–60 %

2,075

15.3

 Highest 61–80 %

2,840

20.9

 Highest 81–100 %

4,334

31.9

 Unknown

353

2.6

Method of diagnosis

 TRUS

11,518

84.7

 TURP

1,239

9.1

 Other

841

6.2

PSA (ng/mL)

  < 4

2,691

19.8

 4.01–10

5,985

44.0

 10.01–20

1,820

13.4

  > 20.01

1,284

9.4

 Unknown

1,818

13.4

Grade Group

 Grade Group 1 (Gleason score ≤ 6)

4,769

35.1

 Grade Group 2 (Gleason score 3 + 4)

3,771

27.7

 Grade Group 3 (Gleason score 4 + 3)

1,832

13.5

 Grade Group 4 (Gleason score 8)

1,264

9.3

 Grade Group 5 (Gleason score >8)

1,193

8.8

 Unknown

769

5.7

NCCN Risk

 Low

3,352

24.7

 Intermediate

5,727

42.1

 High

2,943

21.6

 Very high/Metastatic

546

4.0

 Unknown

1,030

7.6

  1. SA South Australia, SEIFA Socio-Economic Index of Advantage and Disadvantage, NCCN National Comprehensive Cancer Network, GS Gleason Score, PSA Prostate Specific Antigen, TURP Transurethral Resection of the Prostate, TRUS Transrectal Ultrasonography of the Prostate